FDA panel votes against panobinostat as add-on therapy for multiple myeloma
Read the full story on MD Consult:
FDA panel votes against panobinostat as add-on therapy for multiple myeloma
Source: MD Consult: News: Top Stories - Category: Journals (General) Source Type: news
More News: General Medicine | Myeloma